Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Youcare Pharmaceutical Group Co's EV-to-FCF or its related term are showing as below:
SHSE:688658'
s EV-to-FCF Range Over the Past 10 Years
Min: -438.44 Med: 14.92 Max: 175.93
Current: 25.08
During the past 9 years, the highest EV-to-FCF of Youcare Pharmaceutical Group Co was 175.93. The lowest was -438.44. And the median was 14.92.
SHSE:688658's EV-to-FCF is ranked worse than 62.87% of 334
companies
in the Biotechnology industry
Industry Median: 15.69
vs SHSE:688658: 25.08
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Youcare Pharmaceutical Group Co (SHSE:688658) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Youcare Pharmaceutical Group Co's PE Ratio (TTM) for today is calculated as:
Youcare Pharmaceutical Group Co's share price for today is ¥12.97.
Youcare Pharmaceutical Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.550.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Youcare Pharmaceutical Group Co EV-to-FCF Related Terms
Youcare Pharmaceutical Group Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688658 vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, Youcare Pharmaceutical Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Youcare Pharmaceutical Group Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Youcare Pharmaceutical Group Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Youcare Pharmaceutical Group Co's EV-to-FCF falls into.
Youcare Pharmaceutical Group Co's current Enterprise Value is ¥5,020 Mil.
Youcare Pharmaceutical Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥200 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Youcare Pharmaceutical Group Co (SHSE:688658) has a EV-to-FCF of 25.08 as of Jul. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Youcare Pharmaceutical Group Co and its competitors. This is 68% above median its historical median of 14.92. According to the industry distribution chart, Youcare Pharmaceutical Group Co ranks #210 out of 334 companies in the Biotechnology industry, placing it in the top 62.9%.
Is Youcare Pharmaceutical Group Co's EV-to-FCF too high?
Youcare Pharmaceutical Group Co's current EV-to-FCF of 25.08 is 68% above median its 10-year median of 14.92. The Biotechnology industry median EV-to-FCF is 15.69. Youcare Pharmaceutical Group Co's value of 25.08 is 59.8% above this industry median. Based on the distribution chart, Youcare Pharmaceutical Group Co ranks #210 out of 334 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Youcare Pharmaceutical Group Co has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Youcare Pharmaceutical Group Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Youcare Pharmaceutical Group Co ranks #210 out of 334 companies for EV-to-FCF. This places Youcare Pharmaceutical Group Co in the lower half of its industry. The industry median EV-to-FCF is 15.69. Youcare Pharmaceutical Group Co's value of 25.08 is 59.8% above this benchmark. While the company's 10-year median is 14.92 vs. the industry median of 15.69, Youcare Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.69, based on 334 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Youcare Pharmaceutical Group Co's current EV-to-FCF of 25.08 is 59.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Youcare Pharmaceutical Group Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Youcare Pharmaceutical Group Co's current EV-to-FCF is 25.08, which is 68% above median its own 10-year median of 14.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Youcare Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co (SHSE:688658) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥11.05, compared to a current price of ¥12.97 — trading 17.4% above its estimated fair value. The current EV-to-FCF is 25.08, which is 68% above median its 10-year median of 14.92 and 59.8% above the Biotechnology industry median of 15.69. Youcare Pharmaceutical Group Co's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Youcare Pharmaceutical Group Co (SHSE:688658), the current EV-to-FCF is 25.08 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Youcare Pharmaceutical Group Co (SHSE:688658) Overvalued in 2026?
Based on GuruFocus' analysis, Youcare Pharmaceutical Group Co stock appears to be overvalued.
The current stock price of ¥12.97 is trading 17.4% above its estimated GF Value™ of ¥11.05.
GuruFocus considers Youcare Pharmaceutical Group Co to be Modestly Overvalued.
Key valuation signals for SHSE:688658:
EV-to-FCF: 25.08 (68% above median its 10-year median of 14.92)
GF Value™: ¥11.05 vs. price of ¥12.97 (17.4% above fair value)
Industry Position: 59.8% above the Biotechnology median (#210 of 334)
No single metric tells the full story. See the SHSE:688658 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Youcare Pharmaceutical Group Co Business Description
Youcare Pharmaceutical Group Co Ltd is a pharmaceutical group enterprise integrating new drug research and development, drug production, circulation and sales.
52GF Score
Get the complete analysis for SHSE:688658
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688658 has been successfully added to your 
